Genmab A/S (GMAB)
USD 20.17
(0.47%)
USD 20.17
(0.47%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 5.56 Billion DKK | -19.81% |
| 2022 | 7.04 Billion DKK | 103.38% |
| 2021 | 3.14 Billion DKK | -48.74% |
| 2020 | 6.54 Billion DKK | 133.21% |
| 2019 | 2.77 Billion DKK | 70.41% |
| 2018 | 1.46 Billion DKK | 49.61% |
| 2017 | 1.48 Billion DKK | -3.0% |
| 2016 | 1.09 Billion DKK | 48.38% |
| 2015 | 585.98 Million DKK | 151.64% |
| 2014 | 277.5 Million DKK | 155.9% |
| 2013 | 80.91 Million DKK | 125.98% |
| 2012 | -96.24 Million DKK | 11.35% |
| 2011 | -192.74 Million DKK | -121.89% |
| 2010 | -61.76 Million DKK | 73.23% |
| 2009 | -77.1 Million DKK | -1.89% |
| 2008 | -879.41 Million DKK | -138.99% |
| 2007 | -317.72 Million DKK | 12.33% |
| 2006 | -419.7 Million DKK | -16.43% |
| 2005 | -360.46 Million DKK | -23.04% |
| 2004 | 537.45 Million DKK | -62.94% |
| 2003 | 474.55 Million DKK | -126.85% |
| 2002 | 669.75 Million DKK | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 1.09 Billion DKK | -50.23% |
| 2024 Q2 | 2.1 Billion DKK | 149.25% |
| 2023 Q4 | 1.96 Billion DKK | 0.26% |
| 2023 Q1 | 629 Million DKK | -77.58% |
| 2023 FY | - DKK | -19.81% |
| 2023 Q2 | 1.7 Billion DKK | 171.22% |
| 2023 Q3 | 1.96 Billion DKK | 14.89% |
| 2022 FY | - DKK | 103.38% |
| 2022 Q4 | 2.8 Billion DKK | 38.31% |
| 2022 Q1 | 550 Million DKK | -34.83% |
| 2022 Q2 | 2.68 Billion DKK | 388.91% |
| 2022 Q3 | 2.02 Billion DKK | -24.58% |
| 2021 FY | - DKK | -48.74% |
| 2021 Q1 | 1.42 Billion DKK | 1214.84% |
| 2021 Q3 | 1.4 Billion DKK | 64.44% |
| 2021 Q4 | 844 Million DKK | -39.76% |
| 2021 Q2 | 852 Million DKK | -40.29% |
| 2020 Q3 | 1.39 Billion DKK | -69.41% |
| 2020 FY | - DKK | 133.21% |
| 2020 Q1 | 356 Million DKK | -81.87% |
| 2020 Q2 | 4.54 Billion DKK | 1177.25% |
| 2020 Q4 | -128 Million DKK | -109.2% |
| 2019 Q2 | 110.52 Million DKK | 15.12% |
| 2019 FY | - DKK | 70.41% |
| 2019 Q4 | 1.96 Billion DKK | 180.78% |
| 2019 Q3 | 699.27 Million DKK | 532.67% |
| 2019 Q1 | 96.01 Million DKK | -87.86% |
| 2018 Q3 | 230.59 Million DKK | -31.23% |
| 2018 Q4 | 790.57 Million DKK | 242.84% |
| 2018 Q1 | 255.7 Million DKK | -61.36% |
| 2018 FY | - DKK | 49.61% |
| 2018 Q2 | 335.31 Million DKK | 31.14% |
| 2017 FY | - DKK | -3.0% |
| 2017 Q4 | 661.74 Million DKK | 9279.43% |
| 2017 Q3 | -7.2 Million DKK | -101.84% |
| 2017 Q2 | 390.94 Million DKK | 1808.7% |
| 2017 Q1 | 20.48 Million DKK | -97.39% |
| 2016 Q1 | -11.51 Million DKK | -103.0% |
| 2016 FY | - DKK | 48.38% |
| 2016 Q3 | 188.95 Million DKK | 12.32% |
| 2016 Q2 | 168.23 Million DKK | 1561.47% |
| 2016 Q4 | 784.54 Million DKK | 315.2% |
| 2015 FY | - DKK | 151.64% |
| 2015 Q1 | 217.3 Million DKK | 236.1% |
| 2015 Q4 | 383.58 Million DKK | 173.47% |
| 2015 Q3 | 140.26 Million DKK | 750.67% |
| 2015 Q2 | 16.48 Million DKK | -92.41% |
| 2014 Q4 | 64.65 Million DKK | -59.63% |
| 2014 FY | - DKK | 155.9% |
| 2014 Q3 | 160.14 Million DKK | 711.18% |
| 2014 Q2 | -26.2 Million DKK | -125.99% |
| 2014 Q1 | 100.8 Million DKK | 80.27% |
| 2013 Q1 | 72.25 Million DKK | 120.12% |
| 2013 FY | - DKK | 125.98% |
| 2013 Q4 | 55.91 Million DKK | 944.4% |
| 2013 Q3 | 5.35 Million DKK | 122.7% |
| 2013 Q2 | -23.58 Million DKK | -132.65% |
| 2012 Q4 | -359.08 Million DKK | -1498.7% |
| 2012 Q3 | -22.46 Million DKK | -1128.91% |
| 2012 Q2 | 2.18 Million DKK | 103.36% |
| 2012 Q1 | -65.01 Million DKK | -61.85% |
| 2012 FY | - DKK | 11.35% |
| 2011 Q2 | -74.92 Million DKK | 27.95% |
| 2011 Q1 | -103.99 Million DKK | -35.52% |
| 2011 Q3 | -356.31 Million DKK | -375.54% |
| 2011 Q4 | -40.17 Million DKK | 88.73% |
| 2011 FY | - DKK | -121.89% |
| 2010 Q3 | -10.78 Million DKK | 85.08% |
| 2010 Q1 | -119.77 Million DKK | 79.92% |
| 2010 Q4 | -76.73 Million DKK | -611.75% |
| 2010 Q2 | -72.26 Million DKK | 39.67% |
| 2010 FY | - DKK | 73.23% |
| 2009 Q4 | -596.54 Million DKK | -810.91% |
| 2009 FY | - DKK | -1.89% |
| 2009 Q2 | -89.03 Million DKK | 47.62% |
| 2009 Q1 | -169.99 Million DKK | 0.0% |
| 2009 Q3 | -65.48 Million DKK | 26.45% |
| 2008 FY | - DKK | -138.99% |
| 2007 FY | - DKK | 12.33% |
| 2006 FY | - DKK | -16.43% |
| 2005 FY | - DKK | -23.04% |
| 2004 FY | - DKK | -62.94% |
| 2003 FY | - DKK | -126.85% |
| 2002 FY | - DKK | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Dyadic International, Inc. | -8.22 Million USD | 67672.009% |
| Agenus Inc. | -145.92 Million USD | 3910.888% |
| AlloVir, Inc. | -190.14 Million USD | 3024.595% |
| Ardelyx, Inc. | -55.35 Million USD | 10146.248% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | 25918.283% |
| Chimerix, Inc. | -92.97 Million USD | 6081.242% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | 12614.431% |
| CRISPR Therapeutics AG | -202.7 Million USD | 2843.45% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | 7290.05% |
| Fate Therapeutics, Inc. | -172.22 Million USD | 3328.841% |
| Fortress Biotech, Inc. | -133.64 Million USD | 4261.086% |
| Fortress Biotech, Inc. | -133.64 Million USD | 4261.086% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | 1911096.564% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | 3631204.349% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | 55235.832% |
| IO Biotech, Inc. | -91.22 Million USD | 6195.716% |
| Structure Therapeutics Inc. | -102.45 Million USD | 5527.537% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | -5366.592% |
| MiMedx Group, Inc. | 40.51 Million USD | -13625.103% |
| Senti Biosciences, Inc. | -61.33 Million USD | 9166.454% |
| Opthea Limited | -200.01 Million USD | 2880.239% |
| Pharming Group N.V. | 9.87 Million USD | -56202.521% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | 24531.069% |
| PureTech Health plc | -11.62 Million USD | 47928.331% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | 32848.366% |
| Elevation Oncology, Inc. | -41.46 Million USD | 13510.664% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | 6460.735% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | 1563.54% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | 3637.644% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | 91017.325% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | -1051128.733% |
| PDS Biotechnology Corporation | -40.08 Million USD | 13973.031% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | 2518.436% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | 1732498.754% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | 9040.946% |
| Wave Life Sciences Ltd. | -58.79 Million USD | 9559.092% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | 23529.534% |
| Clearside Biomedical, Inc. | -23.05 Million USD | 24217.443% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | 23163.302% |
| Molecular Templates, Inc. | 1.43 Million USD | -388781.119% |
| Sorrento Therapeutics, Inc. | -539.92 Million USD | 1129.952% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | 80881.522% |
| Vaxxinity, Inc. | -56.05 Thousand USD | 9921421.653% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | 11966.758% |
| Aadi Bioscience, Inc. | -65.36 Million USD | 8607.611% |
| Aptorum Group Limited | -9.59 Million USD | 58033.136% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | 18947.014% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | 4363.884% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | 66333.921% |
| Akebia Therapeutics, Inc. | -6.86 Million USD | 81069.715% |
| ContextLogic Inc. | -324 Million USD | 1816.358% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | 3461.726% |
| C4 Therapeutics, Inc. | -122.1 Million USD | 4654.352% |
| ESSA Pharma Inc. | -26.45 Million USD | 21120.355% |
| Pyxis Oncology, Inc. | -78.49 Million USD | 7184.708% |
| Royalty Pharma plc | 1.88 Billion USD | -194.658% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | 2790.464% |
| TG Therapeutics, Inc. | 26.1 Million USD | -21206.513% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | 9792.217% |
| Janux Therapeutics, Inc. | -71.02 Million USD | 7929.748% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | 31040.081% |
| Seer, Inc. | -97.88 Million USD | 5781.156% |
| MEI Pharma, Inc. | 26.38 Million USD | -20980.364% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | 43159180.132% |
| NextCure, Inc. | -59.03 Million USD | 9519.197% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | -248714.318% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | 17235.55% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | 3596.407% |
| AnaptysBio, Inc. | -143.16 Million USD | 3984.356% |
| ChromaDex Corporation | -3.89 Million USD | 142909.45% |
| Precigen, Inc. | -89.22 Million USD | 6332.488% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | 6078.413% |
| Caribou Biosciences, Inc. | -112.53 Million USD | 5041.618% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | 19300.359% |
| Acelyrin, Inc. | -381.52 Million USD | 1557.568% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | 16756.682% |
| Psyence Biomedical Ltd. | -2.75 Million USD | 202202.065% |
| Keros Therapeutics, Inc. | -152.17 Million USD | 3754.297% |
| Lantern Pharma Inc. | -15.78 Million USD | 35325.879% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | 7533.014% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | 23163.302% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | 77713.398% |
| AbCellera Biologics Inc. | -192.15 Million USD | 2993.973% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | 2253.406% |
| Bicycle Therapeutics plc | -183.4 Million USD | 3132.17% |
| GlycoMimetics, Inc. | -39.12 Million USD | 14314.511% |
| Incyte Corporation | 919.42 Million USD | -504.834% |
| Alkermes plc | 495.04 Million USD | -1023.323% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | 10957.299% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | 55888.523% |
| Onconetix, Inc. | -36.7 Million USD | 15249.812% |
| Avidity Biosciences, Inc. | -233.49 Million USD | 2481.615% |
| Geron Corporation | -174.78 Million USD | 3281.678% |
| Summit Therapeutics Inc. | 1 Million USD | -555444.456% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | 5051.738% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | 18094.434% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 27685.694% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | 28027.33% |
| Innoviva, Inc. | 248.96 Million USD | -2133.692% |
| Jaguar Health, Inc. | -33.13 Million USD | 16884.884% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | 9898.428% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | 4531.182% |
| Vaxcyte, Inc. | -464.88 Million USD | 1296.21% |
| ADMA Biologics, Inc. | 5.12 Million USD | -108513.281% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | 3265.559% |
| VYNE Therapeutics Inc. | -29.25 Million USD | 19106.767% |
| Novavax, Inc. | -487.39 Million USD | 1240.975% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | 16585.341% |
| Scopus BioPharma Inc. | -11.71 Million USD | 47576.558% |
| Alzamend Neuro, Inc. | -9.88 Million USD | 56346.115% |
| Compass Therapeutics, Inc. | -48.47 Million USD | 11572.366% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | -6305.796% |
| Precision BioSciences, Inc. | -32.04 Million USD | 17455.346% |
| GT Biopharma, Inc. | 5.97 Million USD | -92908.864% |
| ImmuCell Corporation | -2.5 Million USD | 222177.835% |
| Immix Biopharma, Inc. | -16.13 Million USD | 34564.07% |
| Mesoblast Limited | -61.33 Million USD | 9167.193% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | 2450.162% |
| Aptose Biosciences Inc. | -52.26 Million USD | 10739.397% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | 5261.338% |
| Soligenix, Inc. | -7.85 Million USD | 70915.054% |
| Century Therapeutics, Inc. | -121.2 Million USD | 4687.981% |
| Kura Oncology, Inc. | -164.95 Million USD | 3471.222% |
| TScan Therapeutics, Inc. | -80.09 Million USD | 7042.745% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | 580738.358% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | 129155.465% |
| Autolus Therapeutics plc | -156.77 Million USD | 3647.235% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | 6668.86% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | 8159.303% |
| Eterna Therapeutics Inc. | -19.93 Million USD | 27997.06% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | 3038.084% |
| GRI Bio, Inc. | -10.89 Million USD | 51127.712% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | 123247.719% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | 4639.37% |
| IGM Biosciences, Inc. | -253.35 Million USD | 2294.918% |
| INmune Bio, Inc. | - USD | -Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | 5457.831% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | 14683.086% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | 36373.131% |
| Entero Therapeutics, Inc. | -15.74 Million USD | 35423.093% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | 9882.743% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | 5292.198% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | 2190.625% |
| Coherus BioSciences, Inc. | -193.93 Million USD | 2967.396% |
| Verastem, Inc. | -83.16 Million USD | 6786.627% |
| Abeona Therapeutics Inc. | -50.57 Million USD | 11096.203% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | 3614.549% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | 4974.265% |
| Histogen Inc. | -10.5 Million USD | 53046.777% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | 39043.373% |
| Surrozen, Inc. | -41.13 Million USD | 13620.216% |
| Organovo Holdings, Inc. | -14.8 Million USD | 37659.098% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | -173401833.271% |
| Ovid Therapeutics Inc. | -58.71 Million USD | 9571.468% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | 10941.424% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | 66794.611% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | 3448.665% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | 11389.429% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | 23111.669% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | 37037.799% |
| Apollomics, Inc. | -171.74 Million USD | 3337.902% |
| Amarin Corporation plc | -50.9 Million USD | 11025.015% |
| Turnstone Biologics Corp. | -56.23 Million USD | 9989.035% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | 3983.353% |
| Synaptogenix, Inc. | -8.3 Million USD | 67039.456% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | 36353.993% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | 8920.404% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | 116160.513% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | -1296052.564% |
| Exelixis, Inc. | 196.6 Million USD | -2728.557% |
| Better Therapeutics, Inc. | -38.26 Million USD | 14634.002% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | 4032.564% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | 1222.956% |
| NLS Pharmaceutics AG | -11.79 Million USD | 47244.478% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | -2249349.874% |
| Gritstone bio, Inc. | -126.86 Million USD | 4483.469% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | 8657.359% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | 139126.877% |
| Avid Bioservices, Inc. | -11.48 Million USD | 48536.547% |
| Insmed Incorporated | -654.73 Million USD | 949.346% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | 247286.426% |
| MediWound Ltd. | -4.89 Million USD | 113752.156% |
| OmniAb, Inc. | -49.73 Million USD | 11282.16% |
| Alector, Inc. | -142.89 Million USD | 3991.75% |
| Seres Therapeutics, Inc. | -85.43 Million USD | 6609.118% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | 10763.88% |
| Zai Lab Limited | -366.57 Million USD | 1617.024% |
| Revance Therapeutics, Inc. | -290.63 Million USD | 2013.383% |
| Aura Biosciences, Inc. | -83.69 Million USD | 6744.284% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | 2568.823% |
| Immunic, Inc. | -99.11 Million USD | 5710.824% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | 4323.437% |
| Veracyte, Inc. | -49.4 Million USD | 11355.035% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | 78823.872% |
| FibroGen, Inc. | -261.4 Million USD | 2227.35% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | 50014.729% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | 79527.789% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | 29811.169% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | -283.67% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | 21974.754% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | -13840.837% |
| Galecto, Inc. | -37.51 Million USD | 14921.824% |
| Calithera Biosciences, Inc. | -38.26 Million USD | 14632.863% |
| Fortrea Holdings Inc. | 167.3 Million USD | -3223.969% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | 4241.346% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | 19742.542% |
| XBiotech Inc. | -35.76 Million USD | 15648.286% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | 8657.359% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | 8622.605% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | 5423.824% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | 21761.733% |
| Theravance Biopharma, Inc. | -40.86 Million USD | 13707.556% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | 1176.766% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | 10026.635% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | 4880.161% |
| Gain Therapeutics, Inc. | -22.16 Million USD | 25183.951% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | 2465.739% |
| NexImmune, Inc. | -28.16 Million USD | 19842.604% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | 100741.602% |
| Marker Therapeutics, Inc. | -11.79 Million USD | 47258.003% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | -19.483% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | 22000.599% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | 4518.893% |
| Ainos, Inc. | -8.77 Million USD | 63486.959% |
| Pluri Inc. | -20.22 Million USD | 27595.674% |
| Prothena Corporation plc | -190.1 Million USD | 3025.179% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | 4437.821% |
| Celularity Inc. | -183.94 Million USD | 3123.17% |
| Rallybio Corporation | -72.37 Million USD | 7783.805% |
| Cue Biopharma, Inc. | -46.05 Million USD | 12175.48% |
| MeiraGTx Holdings plc | -57.05 Million USD | 9847.248% |
| Omeros Corporation | -163.61 Million USD | 3498.936% |
| Humacyte, Inc. | -96.45 Million USD | 5865.204% |
| Immunocore Holdings plc | -59.64 Million USD | 9422.872% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | 28806.38% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | 22923.723% |
| Blueprint Medicines Corporation | -474.61 Million USD | 1271.694% |
| CalciMedica, Inc. | -34.18 Million USD | 16365.466% |
| Cabaletta Bio, Inc. | -73.23 Million USD | 7693.468% |
| Scholar Rock Holding Corporation | -168.45 Million USD | 3401.257% |
| Sana Biotechnology, Inc. | -252.39 Million USD | 2303.336% |
| Pulmatrix, Inc. | -12.64 Million USD | 44074.379% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | 16968.895% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | 6385.96% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | 1198.328% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | 5594.245% |
| Cytokinetics, Incorporated | -456.68 Million USD | 1317.691% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | 16763.171% |
| Nutriband Inc. | -5.12 Million USD | 108675.598% |
| Protara Therapeutics, Inc. | -43.27 Million USD | 12951.266% |
| Vor Biopharma Inc. | -114.37 Million USD | 4962.247% |
| Roivant Sciences Ltd. | -996.51 Million USD | 658.045% |
| Evogene Ltd. | -23.2 Million USD | 24065.696% |
| ProKidney Corp. | -147.66 Million USD | 3865.855% |
| Applied Therapeutics, Inc. | -64.53 Million USD | 8717.03% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | 1083.433% |
| CorMedix Inc. | -48.88 Million USD | 11475.205% |
| BioLineRx Ltd. | -57.06 Million USD | 9845.711% |
| Tango Therapeutics, Inc. | -111.75 Million USD | 5075.93% |
| Galectin Therapeutics Inc. | -202 Thousand USD | 2753070.297% |
| Atai Life Sciences N.V. | -36.31 Million USD | 15414.918% |
| Renovaro Biosciences Inc. | -79.51 Million USD | 7093.474% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | 6939.005% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | 2118.49% |
| Sagimet Biosciences Inc. | -30.74 Million USD | 18190.436% |
| MediciNova, Inc. | -9.87 Million USD | 56385.596% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | 4515.56% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | 363516.309% |
| GeoVax Labs, Inc. | -26.66 Million USD | 20952.105% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | 2571.654% |
| Biomea Fusion, Inc. | -124.62 Million USD | 4562.366% |
| PTC Therapeutics, Inc. | -330.34 Million USD | 1783.417% |
| Mereo BioPharma Group plc | -26.05 Million USD | 21442.493% |
| Cullinan Oncology, Inc. | -190.33 Million USD | 3021.629% |
| Absci Corporation | -95.45 Million USD | 5925.66% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | 18621.232% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | 5291.471% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | 2481.829% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | 24431.656% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | 2775.667% |
| Allakos Inc. | -189.91 Million USD | 3028.152% |
| Imunon, Inc. | -19.87 Million USD | 28075.259% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | 5225.724% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | -5033.673% |
| BioAtla, Inc. | -122.24 Million USD | 4649.21% |
| NLS Pharmaceutics AG | -11.79 Million USD | 47244.478% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | 35383.294% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | 1951.858% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | 13517.135% |
| XOMA Corporation | -39.36 Million USD | 14227.839% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | 5702.797% |
| Cara Therapeutics, Inc. | -117.65 Million USD | 4826.732% |
| aTyr Pharma, Inc. | -52.17 Million USD | 10757.748% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | 6734.851% |
| Akero Therapeutics, Inc. | -148.63 Million USD | 3841.481% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | 2470.771% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | 40830.975% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | 69246.886% |
| Akari Therapeutics, Plc | -16.8 Million USD | 33197.25% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | -2946812.128% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | -1130.454% |
| Lexaria Bioscience Corp. | -6.38 Million USD | 87145.334% |
| UroGen Pharma Ltd. | -63.83 Million USD | 8812.068% |
| Sutro Biopharma, Inc. | -67.91 Million USD | 8288.176% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | 76666.031% |
| Orgenesis Inc. | -60.71 Million USD | 9258.734% |
| Entera Bio Ltd. | -8.8 Million USD | 63264.471% |
| GH Research PLC | -41.15 Million USD | 13612.988% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | 21891.606% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | 6862.492% |
| Xencor, Inc. | -125.87 Million USD | 4517.91% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | 389922.964% |
| Replimune Group, Inc. | -230.19 Million USD | 2515.746% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | 27687.585% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | 50922.519% |
| Lexaria Bioscience Corp. | -6.38 Million USD | 87145.334% |
| Portage Biotech Inc. | -18.19 Million USD | 30656.624% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | 363516.309% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | 5417.257% |
| OncoCyte Corporation | -23.12 Million USD | 24149.648% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | 49310.813% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | 48638.694% |
| Purple Biotech Ltd. | -22.22 Million USD | 25121.372% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | 86855.07% |
| scPharmaceuticals Inc. | -46.06 Million USD | 12173.12% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | 31324.589% |
| HilleVax, Inc. | -132.46 Million USD | 4298.058% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | 52399.445% |
| Tharimmune, Inc. | -9.3 Million USD | 59879.057% |
| Genprex, Inc. | -31.06 Million USD | 18003.73% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | 3065.455% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | 17836.174% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | 727979.581% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | -3685024.317% |
| OKYO Pharma Limited | -15.74 Thousand USD | 35317297.462% |
| Savara Inc. | -59.13 Million USD | 9504.224% |
| Curis, Inc. | -45.13 Million USD | 12419.724% |
| Daré Bioscience, Inc. | -30.7 Million USD | 18213.111% |
| Carmell Therapeutics Corporation | -15.19 Million USD | 36706.845% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | 20901.227% |
| BeiGene, Ltd. | -1.12 Billion USD | 594.482% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | 34214.053% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | 1391.508% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | 6255.634% |
| Erasca, Inc. | -121.31 Million USD | 4684.123% |
| bluebird bio, Inc. | -167.16 Million USD | 3426.733% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | 123711.95% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | -1692.229% |
| DBV Technologies S.A. | -85.98 Million USD | 6567.633% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | 123711.95% |
| Moderna, Inc. | -3.28 Billion USD | 269.388% |
| Vincerx Pharma, Inc. | -42.6 Million USD | 13151.233% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | 98559.632% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | 9391.252% |
| Travere Therapeutics, Inc. | -326.24 Million USD | 1804.542% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | 4156.489% |
| Spruce Biosciences, Inc. | -47.36 Million USD | 11840.489% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | 4099.741% |
| Cogent Biosciences, Inc. | -205.86 Million USD | 2801.35% |
| MacroGenics, Inc. | 2.01 Million USD | -275606.495% |
| RenovoRx, Inc. | -11.39 Million USD | 48923.529% |
| Adicet Bio, Inc. | -136.53 Million USD | 4172.948% |
| Prime Medicine, Inc. | -193.75 Million USD | 2970.06% |
| Aditxt, Inc. | -25.45 Million USD | 21943.852% |
| Adagene Inc. | -14.95 Million USD | 37295.371% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | 76172.852% |
| Quantum-Si incorporated | -91.8 Million USD | 6157.47% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | -680.591% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | -4297.612% |
| SciSparc Ltd. | -5.28 Million USD | 105382.09% |
| Vericel Corporation | 2.86 Million USD | -194068.994% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | 5840995.723% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | 25736.854% |
| Generation Bio Co. | -133.3 Million USD | 4271.793% |
| Astria Therapeutics, Inc. | -83.03 Million USD | 6797.579% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | 6564.55% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | 2545.105% |
| Invivyd, Inc. | -196.61 Million USD | 2928.37% |
| Relay Therapeutics, Inc. | -374.15 Million USD | 1586.29% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | 60058.179% |
| Spero Therapeutics, Inc. | 27.15 Million USD | -20379.487% |
| Artelo Biosciences, Inc. | -10.28 Million USD | 54169.033% |
| 2seventy bio, Inc. | -206.41 Million USD | 2794.048% |
| Clene Inc. | -43.24 Million USD | 12960.48% |
| Capricor Therapeutics, Inc. | -23 Million USD | 24268.828% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | 11571.419% |
| GeoVax Labs, Inc. | -26.66 Million USD | 20952.105% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | 1956.352% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | 15240.48% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | -23490.549% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | -113152.774% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | 17220.251% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | 3610.644% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 912.649% |
| Evaxion Biotech A/S | -21.4 Million USD | 26082.339% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | 8473.108% |
| Verve Therapeutics, Inc. | -217.66 Million USD | 2654.797% |
| Trevena, Inc. | -35.28 Million USD | 15858.898% |
| Surrozen, Inc. | -41.13 Million USD | 13620.216% |
| Tyra Biosciences, Inc. | -79.59 Million USD | 7086.883% |
| Cingulate Inc. | -22.95 Million USD | 24328.793% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | 74634.245% |
| Unity Biotechnology, Inc. | -37.28 Million USD | 15015.645% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | 67699.674% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | 5537.78% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | 8298.8% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | 9626.828% |
| Clearmind Medicine Inc. | -8.71 Million USD | 63941.298% |
| Kronos Bio, Inc. | -121.83 Million USD | 4664.557% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | 7580.294% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | 227877.837% |
| Viking Therapeutics, Inc. | -100.82 Million USD | 5615.388% |
| Statera Biopharma, Inc. | 38.93 Million USD | -14182.796% |
| ImmunityBio, Inc. | -436.18 Million USD | 1374.927% |
| Korro Bio, Inc. | -80.9 Million USD | 6973.579% |
| Kineta, Inc. | -15.71 Million USD | 35488.825% |
| BioVie Inc. | -31.95 Million USD | 17505.208% |
| Codexis, Inc. | -49.28 Million USD | 11383.81% |
| Celularity Inc. | -183.94 Million USD | 3123.17% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | 2610.496% |
| Celcuity Inc. | -58.3 Million USD | 9636.965% |
| Virax Biolabs Group Limited | -6.6 Million USD | 84241.002% |
| Cibus, Inc. | -314.58 Million USD | 1867.726% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | -28.5 Million USD | 19609.543% |
| Kodiak Sciences Inc. | -259.02 Million USD | 2246.914% |
| Annexon, Inc. | -141.57 Million USD | 4027.953% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | 5038.765% |
| Assembly Biosciences, Inc. | -64.19 Million USD | 8762.533% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | 19992.685% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | 2517.721% |
| Eyenovia, Inc. | -24.1 Million USD | 23168.911% |
| Puma Biotechnology, Inc. | 44.78 Million USD | -12317.381% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | 1716458.025% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | 7634.822% |
| Arcellx, Inc. | -64.14 Million USD | 8769.421% |
| Cardiff Oncology, Inc. | -45.01 Million USD | 12453.934% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | 4603.709% |
| Regulus Therapeutics Inc. | -30.88 Million USD | 18107.253% |
| Moolec Science SA | -52.07 Million USD | 10778.718% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | 10875.879% |
| LAVA Therapeutics N.V. | -40.41 Million USD | 13859.062% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | 4749.938% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | 59740.16% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | 26911.946% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | 3448.386% |
| Humacyte, Inc. | -96.45 Million USD | 5865.204% |
| 89bio, Inc. | -134.46 Million USD | 4235.71% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | 7150.396% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | -137140.869% |
| Genelux Corporation | -24.16 Million USD | 23112.622% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | 16552.663% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | 3501.972% |
| Notable Labs, Ltd. | -14.4 Million USD | 38718.056% |
| Liquidia Corporation | -70.05 Million USD | 8038.502% |
| Mustang Bio, Inc. | -48.06 Million USD | 11670.231% |
| Immunovant, Inc. | -269.97 Million USD | 2159.797% |
| Quantum-Si incorporated | -91.8 Million USD | 6157.47% |
| Arbutus Biopharma Corporation | -70.98 Million USD | 7933.939% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | 28901.533% |
| Vera Therapeutics, Inc. | -102.01 Million USD | 5551.319% |
| Acasti Pharma Inc. | -11.3 Million USD | 49308.035% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | 25089.617% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | 36373.131% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | 2741.642% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | 130323.731% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | 35118.892% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | 19425.132% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | 15117.553% |
| PepGen Inc. | -83.58 Million USD | 6753.346% |
| Moleculin Biotech, Inc. | -29.5 Million USD | 18948.292% |
| United Therapeutics Corporation | 1.38 Billion USD | -300.995% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 24387.025% |
| Solid Biosciences Inc. | -93.43 Million USD | 6051.795% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | 116640.395% |
| Immuneering Corporation | -58.06 Million USD | 9677.89% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | -173401833.271% |
| Silo Pharma, Inc. | -3.62 Million USD | 153455.538% |
| Belite Bio, Inc | -31.52 Million USD | 17737.73% |
| XOMA Corporation | -39.36 Million USD | 14227.839% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | 8344.992% |
| Bionomics Limited | -9.83 Million USD | 56631.492% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | 6721.42% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | 16169.468% |
| uniQure N.V. | -253.1 Million USD | 2297.155% |
| Cassava Sciences, Inc. | -95.68 Million USD | 5911.657% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | 76172.852% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | 4394.076% |
| Forte Biosciences, Inc. | -32.47 Million USD | 17222.887% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | 69176.687% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | 19806.581% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | 1716458.025% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | 50014.729% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | 35072.643% |
| Altimmune, Inc. | -87.93 Million USD | 6423.989% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | 6139.379% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | 16169.468% |
| Compugen Ltd. | -12.51 Million USD | 44531.128% |
| Peak Bio, Inc. | -1356.23 USD | 410033796.349% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | 11542.858% |
| Benitec Biopharma Inc. | -22.49 Million USD | 24826.545% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | 2395.06% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | 19582.885% |
| Zura Bio Limited | -60.56 Million USD | 9282.174% |
| PolyPid Ltd. | -20.26 Million USD | 27544.11% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | 35717.754% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | 19582.885% |
| Instil Bio, Inc. | -146.12 Million USD | 3905.724% |
| argenx SE | -216.02 Million USD | 2674.262% |
| Immunome, Inc. | -28.27 Million USD | 19770.334% |
| Verona Pharma plc | -52.46 Million USD | 10698.925% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | 5967.767% |
| Shattuck Labs, Inc. | -87.61 Million USD | 6447.087% |
| CervoMed Inc. | -2.17 Million USD | 256146.161% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | 4649.099% |
| Plus Therapeutics, Inc. | -12.69 Million USD | 43911.55% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | 11643.571% |
| Moolec Science SA | -52.07 Million USD | 10778.718% |
| Enveric Biosciences, Inc. | -17.13 Million USD | 32544.604% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | 4364.864% |
| Design Therapeutics, Inc. | -66.32 Million USD | 8484.47% |
| Leap Therapeutics, Inc. | -80.98 Million USD | 6966.534% |
| NeurAxis, Inc. | -6.66 Million USD | 83542.181% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | 14831.126% |
| Lumos Pharma, Inc. | -36.57 Million USD | 15306.453% |
| Achilles Therapeutics plc | -70.44 Million USD | 7994.438% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | 5967.767% |
| 180 Life Sciences Corp. | -22.13 Million USD | 25224.213% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | -95298.256% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | 227877.837% |
| Nutriband Inc. | -5.12 Million USD | 108675.598% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | 5167.063% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | 10132.111% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | 11100.989% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | 8619.08% |
| MoonLake Immunotherapeutics | -54.1 Million USD | 10377.225% |
| Palisade Bio, Inc. | -12.28 Million USD | 45381.329% |
| Tourmaline Bio, Inc. | -45.37 Million USD | 12355.377% |
| Beam Therapeutics Inc. | -156.47 Million USD | 3653.968% |
| Neurogene Inc. | -52.28 Million USD | 10735.734% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | 4174.291% |
| AEON Biopharma, Inc. | -48.36 Million USD | 11598.935% |
| Sesen Bio, Inc. | -50.84 Million USD | 11038.238% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | 6887.336% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | 45128.256% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | 1401.026% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | 5386.272% |
| Athira Pharma, Inc. | -116.7 Million USD | 4865.087% |
| Vaccinex, Inc. | -19.74 Million USD | 28259.814% |
| HCW Biologics Inc. | -23.57 Million USD | 23687.491% |
| XOMA Corporation | -39.36 Million USD | 14227.839% |
| Nektar Therapeutics | -243.1 Million USD | 2387.47% |
| Arvinas, Inc. | -394.8 Million USD | 1508.561% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | -2946812.128% |
| Merus N.V. | -149.2 Million USD | 3827.037% |
| Omega Therapeutics, Inc. | -93.49 Million USD | 6048.23% |
| Quince Therapeutics, Inc. | -31.26 Million USD | 17889.507% |
| Rezolute, Inc. | -68.42 Million USD | 8227.384% |
| Clene Inc. | -43.24 Million USD | 12960.48% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | 36158.433% |
| BeyondSpring Inc. | -21.54 Million USD | 25917.084% |
| Synlogic, Inc. | -55.16 Million USD | 10181.398% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | 46123.339% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | 52355.215% |
| Peak Bio, Inc. | -1356.23 USD | 410033796.349% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | 17229.216% |
| Krystal Biotech, Inc. | 17.9 Million USD | -30960.098% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | 4795.878% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | 1729.139% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | 120822.503% |
| MannKind Corporation | 15.12 Million USD | -36657.221% |
| Ikena Oncology, Inc. | -74.39 Million USD | 7574.764% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | 44259.454% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | -27257.702% |
| Gossamer Bio, Inc. | -172.15 Million USD | 3330.285% |
| CohBar, Inc. | -12.06 Million USD | 46189.102% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | 21900.149% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | 18621.232% |
| Legend Biotech Corporation | -477.87 Million USD | 1263.698% |
| Mural Oncology plc | -192.72 Million USD | 2985.533% |
| Biora Therapeutics, Inc. | -114.05 Million USD | 4975.761% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | 34543.524% |
| Disc Medicine, Inc. | -91.02 Million USD | 6209.311% |
| Champions Oncology, Inc. | -5.05 Million USD | 110131.658% |
| REGENXBIO Inc. | -239.46 Million USD | 2422.27% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | 51983.775% |
| Anavex Life Sciences Corp. | -55.75 Million USD | 10073.814% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | 14444.205% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | 5029.702% |
| Vaxart, Inc. | -74.72 Million USD | 7542.153% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | 15894.573% |
| Cellectis S.A. | -98.09 Million USD | 5768.994% |
| Longeveron Inc. | -20.06 Million USD | 27821.834% |
| Repare Therapeutics Inc. | -114.27 Million USD | 4966.416% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | 1366.177% |
| Inozyme Pharma, Inc. | -74.81 Million USD | 7533.299% |
| Revolution Medicines, Inc. | -430.58 Million USD | 1391.508% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | 88524.233% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | 18161.645% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | 7555.423% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | -113320.355% |
| Anixa Biosciences, Inc. | -10.96 Million USD | 50815.914% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | -20.755% |
| Denali Therapeutics Inc. | -179.97 Million USD | 3189.908% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | 5840995.723% |
| Veru Inc. | -89.97 Million USD | 6280.566% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | 20789.783% |
| Cingulate Inc. | -22.95 Million USD | 24328.793% |
| Passage Bio, Inc. | -98.34 Million USD | 5754.813% |
| Context Therapeutics Inc. | -25.06 Million USD | 22290.236% |
| Exicure, Inc. | -15.53 Million USD | 35887.374% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | 2798.676% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | 15139.485% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | 93364.746% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | 3401.002% |
| Nuvalent, Inc. | -149.49 Million USD | 3819.932% |
| ABVC BioPharma, Inc. | -8.13 Million USD | 68480.672% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | 6574.259% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | 18527.331% |
| OmniAb, Inc. | -49.73 Million USD | 11282.16% |
| Anew Medical, Inc. | -1.3 Million USD | 427593.005% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | 45077.354% |
| Lipocine Inc. | -16.32 Million USD | 34169.189% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | 8441.083% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | 7584.22% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | 14683.086% |
| G1 Therapeutics, Inc. | -39.01 Million USD | 14353.858% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | 25168.746% |
| Sage Therapeutics, Inc. | -545.07 Million USD | 1120.236% |
| Ocugen, Inc. | -64.82 Million USD | 8678.216% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | 6107.346% |
| Q32 Bio Inc. | -86.5 Million USD | 6528.753% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | 32952.839% |
| Alumis Inc. Common Stock | -156.89 Million USD | 3644.522% |
| Equillium, Inc. | -12.13 Million USD | 45914.797% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | 9610.535% |
| Coya Therapeutics, Inc. | -7.9 Million USD | 70462.577% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | 29584.161% |
| Galera Therapeutics, Inc. | -46.69 Million USD | 12009.963% |
| Evelo Biosciences, Inc. | -106.34 Million USD | 5329.207% |
| Comera Life Sciences Holdings, Inc. | -17.88 Million USD | 31190.331% |
| Dominari Holdings Inc. | -22.44 Million USD | 24881.64% |
| Edesa Biotech, Inc. | -8.19 Million USD | 67998.701% |
| vTv Therapeutics Inc. | -25.41 Million USD | 21983.362% |
| Bio-Techne Corporation | 326.66 Million USD | -1602.366% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | 1544.926% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | -2469.909% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | 4341.541% |
| Candel Therapeutics, Inc. | -37.43 Million USD | 14956.67% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | 3780.32% |
| Nkarta, Inc. | -120.48 Million USD | 4715.666% |
| BioCardia, Inc. | -11.56 Million USD | 48205.536% |
| Iterum Therapeutics plc | -34.58 Million USD | 16181.55% |